A mobile utility for self-administered hearing frequency screenings and biological ear-age estimation.
The App DNA
What makes this app unique?
Users hire this tool to validate their hearing health or calibrate audio hardware without the cost of a professional clinical visit.
For Individuals interested in self-monitoring their hearing health and high-frequency auditory perception at home.
Key features
Measures hearing ability across a spectrum from 125 Hz to 8000 Hz with visual graph output.
Plays high-frequency tones up to 20,000 Hz to estimate biological ear age based on frequency perception thresholds.
Enables self-administered hearing checks using the device microphone and speaker hardware.
How much does it cost?
The app operates as a free utility with no visible subscription or IAP gates.
Velocity
Dormant developmentopaqueShow more...
The app has not received a single update in the last 11 months, falling well outside the threshold for active development. With only one version recorded in the observed data and no activity since May 2025, the development momentum is classified as zombie. There is no evidence of ongoing maintenance, feature development, or live operations.
Who built it?
Yuichi Sakashita
3 apps tracked · Health & Fitness
Recordable Mirror
Japanese Calendar ConverterUser Sentiment
What do users think recently?
The recent review mood reads mixed. Users appreciate high frequency accuracy provides reliable baseline screening results comparable to professional audiologist testing equipment.
How are ratings & reviews evolving?
What users say, by theme
- High frequency accuracy provides reliable baseline screening results comparable to professional audiologist testing equipment
- Aggressive advertising patterns disrupt the testing flow and force users toward external store pages
30 of 30 recent reviews analyzed · high confidence · Mixed overall
Read the full review analysisUnlock 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Hearing Test & Ear Age Test
How's the Health & Fitness market?
The app maintains a 4.55 rating across 205 reviews, positioning it as a high-utility tool despite the lack of recent feature-rich updates.
Read the market outlookThe rivals identified
By Mimi Hearing Technologies
Mimi is the industry standard for mobile audiometry, offering clinical-grade validation that directly challenges this app's home-testing value proposition.
- Provides medically-certified hearing test results that users can share directly with healthcare professionals
- Integrates with third-party audio hardware to calibrate sound output for personalized hearing profiles
- Maintains a sophisticated clinical-grade UI that builds significantly more user trust than basic tools
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Hearing Test & Ear Age Test
Where is it heading?
The market for mobile hearing diagnostics is consolidating around clinical-grade validation, leaving simple ad-supported utilities vulnerable. The app must transition to a value-added model to retain users who currently use it for long-term health tracking.
- Aggressive advertising disrupts the testing flow → reduces user trust → increases churn risk for power users.
- High clinical-grade accuracy → builds strong user validation → creates a foundation for a paid data-tracking tier.
The SWOT
- Clinical-grade frequency accuracy validated by user audiograms
- Simple interface design lowers the barrier for self-administered screenings
- Paid ad-free tier with result history tracking
- Integration with wearable hardware for continuous monitoring
Next best moves
Ship paid ad-free tier because user requests for result history are frequent → increase LTV
+ 1 more prioritized moveThe counter-intuitive read
The app's lack of medical certification is actually a strength…
Read the full takeFeature gaps
Medically-certified results (available in Mimi Hearing Test) +1
Bottom line
The app sustains a strong reputation for clinical accuracy, but the ad-heavy experience limits its potential, so the PM should prioritize a paid ad-free tier to convert power users and stabilize revenue.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated